Table 3c.
Time to treatment failure: During the follow-up period
Group | No. of Patients | No. of Patients with Treatment Failure | No. of Patients Censored | Median (95% CI) (days) | Hazard Ratio (95% CI) |
---|---|---|---|---|---|
MMF | 33 | 17 | 16 | 386.0 (224.0 to 794.0) | 2.598 (0.87 to 7.75) |
Placebo | 17 | 4 | 13 | not reached (278.0 to not reached) |